Allosteric glutamate modulator starts Phase II for schizophrenia
29 March 2011
Sukaina Virji
Please Login to read the full article.
29 March 2011
Sukaina Virji
sukaina.virji@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Addex seeks partner for dyskinesia drug after positive Phase II
- Positive top-line data for Forest/Richter's antipsychotic cariprazine as filing nears
- Merck hands back preclinical Parkinson's disease assets to Addex
- Lurasidone on track for US bipolar filing following positive top-line PhIII results
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
